论文部分内容阅读
目的观察斯奇康注射液联合左西替利嗪对变应性鼻炎的临床疗效。方法 60例变应性鼻炎患者随机分为治疗组和对照组各30例,治疗组用斯奇康注射液1mg(2mL)肌肉注射,隔日1次,联合左西替利嗪5mg,每日1次口服;对照组单用西替利嗪5mg,每日1次口服,4周为1个疗程。结果 两组近期疗效与远期疗效比较均有显著性差异(P<0.01或P<0.05);嗜酸粒细胞变化:治疗组治疗前、后比较有显著性差异(P<0.01),治疗后与对照组比较差异有显著性(P<0.01)。结论斯奇康联合左西替利嗪对变应性鼻炎具有良好的治疗及控制复发作用,无明显不良反应。
Objective To observe the clinical effect of schizophrenic injection and levocetirizine on allergic rhinitis. Methods Sixty patients with allergic rhinitis were randomly divided into treatment group (n = 30) and control group (n = 30). The treatment group was intramuscularly injected with 1 mg (2 mL) of schizophrenic injection once every other day and levocetirizine 5 mg Times oral; control group with cetirizine 5mg, 1 day orally, 4 weeks for a course of treatment. Results There was a significant difference between the two groups in short-term efficacy and long-term efficacy (P <0.01 or P <0.05). Eosinophil changes: The treatment group had significant difference before and after treatment (P <0.01) Compared with the control group, the difference was significant (P <0.01). Conclusion Szczxe combined with levocetirizine treatment of allergic rhinitis has a good treatment and control of recurrence, no significant adverse reactions.